About this trial
Transcutaneous electrical stimulation of the auricular vagus nerve (TENS) is a promising method of neuromodulation of the autonomic nervous system in patients with various pathologies. The use of this method requires the determination of a reliable biomarker of successful activation of the vagus nerve using TENS. Currently, most studies focus on the assessment of heart rate variability (HRV) as a marker of the functioning of the autonomic nervous system.
Despite the physiological justification of HRV as a biomarker for TENS, the data on the effects of TENS on HRV are ambiguous. In some studies, a significant decrease in the ratio of spectral characteristics (LF/HF) in active TENS was found in comparison with fictitious stimulation (sham), which indicated an increase in the parasympathetic component of HRV. However, other studies have not revealed an increase in HRV.
Eligibility criteria
Qualifiers
Sinus rhythm at the time of registration
Disqualifiers
Frequent ventricular / supraventricular extrasystole, 2d/3d degree AV Block
Taking glucocorticosteroids in the last 1 month
Taking any antiarrhythmics, except beta blockers
Severe chronic renal or liver pathology
Trial design
Treatments tested in this trial
- TENS
Treatment groups
Sponsors and collaborators
Bakulev Scientific Center of Cardiovascular Surgery
Lead sponsor
State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital
Collaborator
Astrakhan Federal Centre For Cardiac Surgery
Collaborator